诊断时 CD70 过表达预测滤泡性淋巴瘤复发并支持 CD19-CD70 双靶点 CAR-T 治疗 CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma. PubMed 2026/07/22 发表BloodQ1 · IF 23.9(JCR 2025) 靶点:CD19靶点:CD70技术:CAR-T弥漫大B细胞淋巴瘤套细胞淋巴瘤滤泡性淋巴瘤
高危 MCL:识别与治疗 High-risk MCL: recognition and treatment. PubMed 2025/02/13 发表BloodQ1 · IF 23.9(JCR 2025) 靶点:CD19靶点:CD70技术:CAR-T技术:双特异性抗体套细胞淋巴瘤淋巴瘤
表达 IL-15 的 CD70 特异性 CAR NK 细胞治疗 CD19 阴性 B 细胞恶性肿瘤 CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy. PubMed 2024/06/11 发表Blood AdvQ1 · IF 7.7(JCR 2025) 靶点:CD19靶点:CD70技术:CAR-T技术:CAR-NK技术:NK 细胞B细胞淋巴瘤淋巴瘤
2022 年套细胞淋巴瘤:分子发病机制、风险分层、临床策略及当前与新型治疗的综合更新 Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatment PubMed 2022/05/01 发表Am J HematolQ1 · IF 9.4(JCR 2025) 靶点:CD19靶点:CD20靶点:CD70技术:CAR-T技术:双特异性抗体套细胞淋巴瘤淋巴瘤